← Back to Clinical Trials
Recruiting NCT06472115

NCT06472115 Parent-Mediated Intervention Targeting Insistence on Sameness for Autistic Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06472115
Status Recruiting
Phase
Sponsor Stanford University
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-01-05
Primary Completion 2027-10-01

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 11 Years
Study Type INTERVENTIONAL
Interventions
Supportive Parenting for Anxious Childhood Emotions (SPACE) for insistence on sameness (IS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-01-05 with a primary completion date of 2027-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will examine the potential effectiveness of a virtually delivered parent-mediated intervention for insistence on sameness behaviors in autism and investigate 1) whether caregivers can learn to deliver the adapted Supportive Parenting for Anxious Childhood emotions (SPACE) intervention for IS via telehealth and 2) whether children will show greater improvement in IS behaviors.

Eligibility Criteria

Inclusion Criteria: * 6:0 to 10:11 years at the time of consent * diagnosed with ASD (based on history, review of available medical records including diagnostic testing completed by psychologist) * IQ \> or = 75 (based on history, review of available medical records) * report three or more family accommodations for insistence on sameness based on screening measures * English-speaking parent and youth able to consistently participate in study procedures Exclusion Criteria: * children with significant hearing, language or motor impairment * unstable behavioral and pharmacological treatments (e.g., anxiety medication) to treat anxiety or IS behaviors prior to two months to the start of the study and no anticipated changes in treatments during the course of the trial * caregivers who have participated in formal SPACE training * concurrent psychosocial treatment for anxiety or Insistence on Sameness * children who have a history of prominent school refusal, self-harm, or suicidal ideation

Contact & Investigator

Central Contact

Kari Berquist, PhD

✉ spacestudy@stanford.edu

📞 (650) 724-6026

Principal Investigator

Jennifer Phillips, PhD

PRINCIPAL INVESTIGATOR

Stanford University

Frequently Asked Questions

Who can join the NCT06472115 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 11 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06472115 currently recruiting?

Yes, NCT06472115 is actively recruiting participants. Contact the research team at spacestudy@stanford.edu for enrollment information.

Where is the NCT06472115 trial being conducted?

This trial is being conducted at Stanford, United States.

Who is sponsoring the NCT06472115 clinical trial?

NCT06472115 is sponsored by Stanford University. The principal investigator is Jennifer Phillips, PhD at Stanford University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology